Peptide Capsules
BPC-157 + TB-500 Blend Capsules
BPC-157 + TB-500 capsules, clearly measured. 500 mcg of each peptide in every capsule, 60 capsules per bottle, at a fixed 1 : 1 ratio.
✓ In stock and ready to ship
Certificate of analysis View available reports and lot details
BPC/TB 500mcg/500mcg
Product identification & intended use
SKU: SC-CAPS-BPC/TB-1000MCG
For laboratory research use only. Not for human or veterinary use.
Description
These capsules put BPC-157 and TB-500 together in a pre-measured oral format: 500 mcg of each in every capsule, 60 capsules per bottle. Available analytical documentation is listed in the COA library.
Chemical identity & storage
| Compound / component | CAS number | Molecular weight | Specification status |
|---|---|---|---|
| BPC-157 | 137525-51-0 | 1419.5 g/mol Formula: C62H98N16O22 |
Catalog reference specification |
| TB-4 fragment (Ac-LKKTETQ) | 885340-08-9 | 889.02 g/mol Formula: C38H68N10O14 |
Formulation-specific label specification for capsules, sprays, GLOW and KLOW. |
This spray/capsule formulation uses the acetylated TB-4 fragment. No single mixture CAS number or molecular weight is assigned.
Storage: Store tightly closed in a cool, dry place at controlled room temperature (15–25°C), protected from heat, light and moisture.
What these capsules are.
This is the capsule form of our equal-ratio BPC-157 + TB-500 vial blend. BPC-157 reportedly survives stomach conditions well, which is why many early studies gave it by mouth. TB-500, a thymosin beta-4-based peptide, brings a separate mechanism built around actin regulation and cell migration.
The capsules deliver both at a fixed 1 : 1 ratio, with nothing to reconstitute.
At a glance.
| BPC-157 | 500 mcg per capsule |
|---|---|
| TB-500 | 500 mcg per capsule |
| Total per capsule | 1 mg peptide |
| Ratio | 1 : 1 |
| Count | 60 capsules |
| Total per bottle | 30 mg BPC-157 + 30 mg TB-500 |
| Catalog reference | SBL-8657 |
What the research looks at.
Both peptides are studied in preclinical models of soft-tissue, gut and wound repair. The case for combining them is that they work differently: BPC-157 work centres on new blood vessels and growth-factor signals; thymosin beta-4 work centres on actin and how cells migrate. The pairing has not been studied clinically, and oral-route data for TB-500 is limited.
Other formats.
The same blend comes as a lyophilized vial or a liquid spray. For single-compound capsules, see BPC-157 and TB-500. With GHK-Cu added, see GLOW capsules.
Documentation.
Available analytical documentation is organized by compound, strength and format in the COA library. Do not treat a report as lot-specific unless a documented lot match is shown.
Handling.
The capsules come pre-measured in a sealed bottle, so there is nothing to reconstitute. Keep the bottle tightly closed somewhere cool and dry, away from heat, humidity and direct light.
Questions.
What is in each capsule?
500 mcg of BPC-157 and 500 mcg of TB-500.
How do these differ from GLOW capsules?
GLOW capsules keep the same BPC-157 and TB-500 and add 2 mg of GHK-Cu to each one.
Is this a supplement?
No. It is sold strictly as laboratory research material.
Further reading.
BPC-157 formats compared: vials, capsules and spray
For laboratory research use only. Not for human or veterinary use.
